10-88823010-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_144590.3(ANKRD22):c.507G>T(p.Glu169Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144590.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD22 | NM_144590.3 | c.507G>T | p.Glu169Asp | missense_variant | 6/6 | ENST00000371930.5 | NP_653191.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD22 | ENST00000371930.5 | c.507G>T | p.Glu169Asp | missense_variant | 6/6 | 1 | NM_144590.3 | ENSP00000360998 | P1 | |
ANKRD22 | ENST00000476963.1 | n.245G>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152112Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251342Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135872
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461164Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726984
GnomAD4 genome AF: 0.000184 AC: 28AN: 152112Hom.: 0 Cov.: 30 AF XY: 0.0000942 AC XY: 7AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.507G>T (p.E169D) alteration is located in exon 6 (coding exon 6) of the ANKRD22 gene. This alteration results from a G to T substitution at nucleotide position 507, causing the glutamic acid (E) at amino acid position 169 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at